HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by GDS Wealth Management

GDS Wealth Management grew its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 43.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 41,131 shares of the company's stock after purchasing an additional 12,493 shares during the period. GDS Wealth Management's holdings in HealthEquity were worth $3,947,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Paladin Wealth LLC purchased a new stake in HealthEquity in the third quarter valued at approximately $39,000. UMB Bank n.a. raised its holdings in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after purchasing an additional 344 shares during the period. Quarry LP increased its position in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after purchasing an additional 1,089 shares during the period. Finally, 1620 Investment Advisors Inc. acquired a new stake in shares of HealthEquity in the third quarter valued at about $112,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

Shares of NASDAQ:HQY traded down $0.55 during trading on Friday, hitting $111.52. The stock had a trading volume of 396,854 shares, compared to its average volume of 750,083. The stock has a 50-day simple moving average of $100.77 and a two-hundred day simple moving average of $89.34. The stock has a market capitalization of $9.66 billion, a price-to-earnings ratio of 102.31, a price-to-earnings-growth ratio of 1.94 and a beta of 0.55. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $113.61. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the company posted $0.40 earnings per share. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now owns 66,469 shares of the company's stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent analyst reports. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective on the stock. Bank of America boosted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. Finally, Barrington Research raised their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, HealthEquity has an average rating of "Moderate Buy" and an average target price of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.